Compare Humana Inc (HUM) vs Union Pacific Corporation (UNP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Union Pacific Corporation — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while Union Pacific Corporation trades at $292.17 (market cap $173.61B). The key difference: Union Pacific Corporation is far larger — about 3.7× Humana Inc's market cap, and Union Pacific Corporation pays the higher dividend (1.94%). Which is the better fit depends on your goals.
| HUM | UNP | |
|---|---|---|
Market Cap | $46.31B | $173.61B |
Sector | Health | Industrials |
52-Week High | $409.42 | $307.32 |
52-Week Low | $163.67 | $214.91 |
Enterprise Value | $53.67B | $202.67B |
Dividend Yield | 0.92% | 1.94% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Union Pacific (UNP) trades at $293.13, down 0.76% on the day, with a neutral technical signal despite bullish moving averages. The company demonstrates strong fundamentals with Q2 2026 EPS beating estimates at $3.41 versus $3.26 expected, while revenue growth and improved operating efficiency support management's raised full-year guidance. Recent dividend increases and institutional accumulation reflect confidence in the railroad operator's service-led growth strategy.
UNP presents a compelling investment case with 58.7% analyst buy ratings and a $334.33 consensus price target implying 14% upside. Key opportunities include pricing power, margin expansion, and domestic intermodal growth, while risks involve high fuel costs, regulatory scrutiny of the Norfolk Southern merger, and macroeconomic pressures on freight volumes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Union Pacific Corporation
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the U.S., UP generated roughly $22 billion of revenue in 2021 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and derives about 10% of its revenue hauling freight to and from Mexico.
Read more on UNP →
